Pharmaceutical

Tenpoint raises funds to develop cell therapies for vision loss

Tenpoint Therapeutics has raised Series A funds of $70m for developing engineered cell-based therapies to reverse vision loss.

Jul 13, 2023 - 20:00
Tenpoint raises funds to develop cell therapies for vision loss
Tenpoint Therapeutics has raised Series A funds of $70m for developing engineered cell-based therapies to reverse vision loss.
Read the original article

Tags:

Previous Article

Roche eyes alternate mode of administration for Ocrevus in MS

Next Article

FDA accepts BeiGene’s sNDA for follicular lymphoma therapy

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A chatbot that’s cautious about GPT, AI pronouncements, and a VC looks to Israel

A chatbot that’s cautious about GPT, AI pronouncements,...

Jun 16, 2023

STAT+: Anthos stroke drug appears safer than common blood thinner in mid-stage trial

STAT+: Anthos stroke drug appears safer than common blo...

Nov 13, 2023

Gilead’s Tecartus escapes harsher classwide boxed warning for CAR-T therapies

Gilead’s Tecartus escapes harsher classwide boxed warni...

Jan 25, 2024